circRNA basic information
circBase ID: hsa_circ_0011780
Name: hsa_circ_MACF1
Synonym: circ_MACF1
Host Gene: MACF1
Genomic location(hg19): chr1:39749737-39793025:+
Genomic location(hg38): chr1:39284065-39327353:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005233
MONDO name: non-small cell lung carcinoma
Disease details: non-small cell lung cancer
Disease DO ID:
3908
Disease MeSH ID:
D002289
Disease NCIt ID:
C2926
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

plasma

Cell lines:

PC9/GR; A549/GR; PC9; A549; HEK293

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: TGFBR2
Associated microRNA: miR-942-5p
Biological function: represses proliferation, migration and invasion; promotes apoptosis; increases gefitinib sensitivity; inhibits tumor growth under gefitinib
Molecular mechanism: circ_MACF1 acts as a sponge of miR-942-5p to de-repress TGFBR2 expression (ceRNA regulation).
Biological pathway or process:

proliferation (inhibits); apoptosis (promotes); migration (inhibits); invasion (inhibits); ceRNA regulation (other); drug resistance (inhibits)

Detected method:
Q
Validation methods:

RT-qPCR; Nuclear-Cytoplasmic Fractionation; RNase R Treatment; Transfection; MTT; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; RNA Pull-Down; In Vivo Animal Model; Western Blot; IHC (Immunohistochemistry); Clinical Sample Validation; Bioinformatics Analysis

Clinical significance:

down-regulated circ_MACF1 in gefitinib-resistant NSCLC plasma vs pre-gefitinib treated plasma, suggesting association with gefitinib resistance

Description:

circ_MACF1 is down-regulated in gefitinib-resistant NSCLC (cells and patient plasma). Restoring circ_MACF1 suppresses malignant behaviors and enhances gefitinib sensitivity by sponging miR-942-5p and thereby increasing TGFBR2 expression, leading to reduced tumor growth under gefitinib in vivo.

Confidence score:

0.8175

Other information
Title:

A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.

Journal: BMC pulmonary medicine
Published: 2022
PubMed ID: 34996416
Study type:

combined biological and clinical study

Data availability: -
Code availability: -